Darvon Maker Pulls Painkiller From US Market
The FDA said Xanodyne Pharmaceuticals Inc. has voluntarily agreed to withdraw Darvon and the related Darvocet drug, both of which contain the controversial pain-killing ingredient propoxyphene.
The agency said it had also informed generic makers of propoxyphene of Xanodyne's decisions and asked that they also remove their products from the U.S. market.
The FDA said it had received new clinical...
To view the full article, register now.